Apple Inc.'s closely watched moves into the health-care sector in recent years has finally resulted in an US FDA-approved product. The tech giant announced Sept. 12 it gained de novo classifications for an electrocardiogram functions and software that will be embedded in the latest Apple Watch.
After several years of skepticism, big tech companies such as Apple, Google and others have been making inroads in recent years with FDA and this approval may be a big...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?